Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Blood Purification|November 2, 2006
The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin CJaromír Eiselt, Jaroslav Racek, Karel Opatrný, et al.
Kidney & Blood Pressure Research|July 27, 2005
Prospective comparison of valacyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipientsTomás Reischig, Karel Opatrný, Vladislav Treska, et al.
Kidney & Blood Pressure Research|November 12, 2003
Tissue factor, its pathway inhibitor, and metabolic disturbances in long-term peritoneal dialysisPavlína Zemanová, Karel Opatrný, Sylvie Opatrná, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 15, 2006
The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejectionTomás Reischig, Pavel Jindra, Miroslava Svecová, et al.
Renal Failure|March 17, 2006
Effect of regional citrate anticoagulation on thrombogenicity and biocompatibility during CVVHDFKamila Polanská, Karel Opatrný, Richard Rokyta, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 24, 2005
Procalcitonin levels in peritoneal dialysis patientsSylvie Opatrná, Jan Klaboch, Karel Opatrný, et al.
Artificial Organs|March 9, 2007
Citrate anticoagulation control by ionized calcium levels does not prevent hemostasis and complement activation during hemodialysisKarel Opatrný, Pavlína Richtrová, Kamila Polanská, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|April 21, 2006
Does an alteration of dialyzer design and geometry affect biocompatibility parameters?Karel Opatrný, Ales Krouzzecký, Kamila Polanská, et al.
Transplantation|February 9, 2005
Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejectionTomás Reischig, Pavel Jindra, Jan Mares, et al.
Artificial Organs|March 7, 2002
Does treatment modality have an impact on anemia in patients with chronic renal failure? Effect of low- and high-flux biocompatible dialysisKarel Opatrný, Tomás Reischig, Jörg Vienken, et al.
Pageof 2